Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pletaal in Ischemic Stroke Patients with PAD
NCT01188824Phase 4Completed
- Sponsor
- China Medical University Hospital
- Start
- Sep 2010
- Primary completion
- Jul 2013
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of cilostazol in Peripheral Arterial Disease (PAD), sponsored by China Medical University Hospital. Primary endpoint: Ankle-Brachial Index at 2 years. Started Sep 2010; status: completed.
02
Drugs
cilostazol
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT01188824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01188824.